Bill Text: IL SB2272 | 2021-2022 | 102nd General Assembly | Introduced
Bill Title: Amends the Clinical Psychologist Licensing Act. In provisions concerning clinical training requirements for a prescribing psychologist license, makes changes to facility requirements for that clinical training. In language providing that a written delegation of prescriptive authority by a collaborating physician may only include medications for the treatment of mental health disease or illness the collaborating physician generally provides to his or her patients in the normal course of his or her clinical practice, deletes an exception for patients who are less than 17 years of age or over 65 years of age. In a provision concerning the delegation of prescriptive authority, removes language providing that no Schedule II controlled substance shall be delegated. Effective immediately.
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: (Introduced - Dead) 2021-05-07 - Rule 3-9(a) / Re-referred to Assignments [SB2272 Detail]
Download: Illinois-2021-SB2272-Introduced.html
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||||
4 | Section 5. The Clinical Psychologist Licensing Act is | |||||||||||||||||||||
5 | amended by changing Sections 4.2 and 4.3 as follows:
| |||||||||||||||||||||
6 | (225 ILCS 15/4.2) | |||||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2027) | |||||||||||||||||||||
8 | Sec. 4.2. Prescribing psychologist license. | |||||||||||||||||||||
9 | (a) A psychologist may apply to the Department for a | |||||||||||||||||||||
10 | prescribing psychologist license. The application shall be | |||||||||||||||||||||
11 | made on a form approved by the Department, include the payment | |||||||||||||||||||||
12 | of any required fees, and be accompanied by evidence | |||||||||||||||||||||
13 | satisfactory to the Department that the applicant: | |||||||||||||||||||||
14 | (1) holds a current license to practice clinical | |||||||||||||||||||||
15 | psychology in Illinois; | |||||||||||||||||||||
16 | (2) has successfully completed the following minimum | |||||||||||||||||||||
17 | educational and training requirements either during the | |||||||||||||||||||||
18 | doctoral program required for licensure under this Section | |||||||||||||||||||||
19 | or in an accredited undergraduate or master level program | |||||||||||||||||||||
20 | prior to or subsequent to the doctoral program required | |||||||||||||||||||||
21 | under this Section: | |||||||||||||||||||||
22 | (A) specific minimum undergraduate biomedical | |||||||||||||||||||||
23 | prerequisite coursework, including, but not limited |
| |||||||
| |||||||
1 | to: Medical Terminology (class or proficiency); | ||||||
2 | Chemistry or Biochemistry with lab (2 semesters); | ||||||
3 | Human Physiology (one semester); Human Anatomy (one | ||||||
4 | semester); Anatomy and Physiology; Microbiology with | ||||||
5 | lab (one semester); and General Biology for science | ||||||
6 | majors or Cell and Molecular Biology (one semester); | ||||||
7 | (B) a minimum of 60 credit hours of didactic | ||||||
8 | coursework, including, but not limited to: | ||||||
9 | Pharmacology; Clinical Psychopharmacology; Clinical | ||||||
10 | Anatomy and Integrated Science; Patient Evaluation; | ||||||
11 | Advanced Physical Assessment; Research Methods; | ||||||
12 | Advanced Pathophysiology; Diagnostic Methods; Problem | ||||||
13 | Based Learning; and Clinical and Procedural Skills; | ||||||
14 | and | ||||||
15 | (C) a full-time practicum of 14 months' supervised | ||||||
16 | clinical training, including a research project; | ||||||
17 | during the clinical rotation phase, students complete | ||||||
18 | rotations in Emergency Medicine, Family Medicine, | ||||||
19 | Geriatrics, Internal Medicine, Obstetrics and | ||||||
20 | Gynecology, Pediatrics, Psychiatrics, Surgery, and one | ||||||
21 | elective of the students' choice . The clinical | ||||||
22 | training must take place at a facility with ; program | ||||||
23 | approval standards addressing faculty qualifications, | ||||||
24 | regular competency evaluation and length of clinical | ||||||
25 | rotations, and instructional settings, including, but | ||||||
26 | not limited to, hospitals, medical centers, health |
| |||||||
| |||||||
1 | care facilities located at federal and State prisons, | ||||||
2 | hospital outpatient clinics, community mental health | ||||||
3 | clinics, patient-centered medical homes or | ||||||
4 | family-centered medical homes, women's medical health | ||||||
5 | centers, and Federally Qualified Health Centers; the | ||||||
6 | clinical training must meet the standards for : | ||||||
7 | (i) accreditation from the Accreditation | ||||||
8 | Review Commission on Education for the Physician | ||||||
9 | Assistant, the Commission on Collegiate Nursing | ||||||
10 | Education for the Advanced Nurse Practitioner, the | ||||||
11 | Accreditation Commission for Education in Nursing | ||||||
12 | for the Advanced Nurse Practitioner, or the | ||||||
13 | Accreditation Council for Graduate Medical | ||||||
14 | Education physician assistant education as defined | ||||||
15 | by the Accreditation Review Commission on | ||||||
16 | Education for the Physician Assistant ; or | ||||||
17 | (ii) an active Memorandum of Understanding | ||||||
18 | with a program accredited by the Accreditation | ||||||
19 | Review Commission on Education for the Physician | ||||||
20 | Assistant, the Commission on Collegiate Nursing | ||||||
21 | Education for the Advanced Nurse Practitioner, the | ||||||
22 | Accreditation Commission for Education in Nursing | ||||||
23 | for the Advanced Nurse Practitioner, or the | ||||||
24 | Accreditation Council for Graduate Medical | ||||||
25 | Education; advanced practice nurse education as | ||||||
26 | defined by the Commission on Collegiate Nursing |
| |||||||
| |||||||
1 | Education for the Advanced Nurse Practitioner or | ||||||
2 | the Accreditation Commission for Education in | ||||||
3 | Nursing for the Advanced Nurse Practitioner; or | ||||||
4 | (iii) medical education as defined by the | ||||||
5 | Accreditation Council for Graduate Medical | ||||||
6 | Education and shall be set by the Department by | ||||||
7 | rule; | ||||||
8 | The training director at the qualified facility must | ||||||
9 | certify that the training meets either the criteria in (i) | ||||||
10 | or (ii); | ||||||
11 | (3) has completed a National Certifying Exam, as | ||||||
12 | determined by rule; and | ||||||
13 | (4) meets all other requirements for obtaining a | ||||||
14 | prescribing psychologist license, as determined by rule. | ||||||
15 | (b) The Department may issue a prescribing psychologist | ||||||
16 | license if it finds that the applicant has met the | ||||||
17 | requirements of subsection (a) of this Section. | ||||||
18 | (c) A prescribing psychologist may only prescribe | ||||||
19 | medication pursuant to the provisions of this Act if the | ||||||
20 | prescribing psychologist: | ||||||
21 | (1) continues to hold a current license to practice | ||||||
22 | psychology in Illinois; | ||||||
23 | (2) satisfies the continuing education requirements | ||||||
24 | for prescribing psychologists, including 10 hours of | ||||||
25 | continuing education annually in pharmacology from | ||||||
26 | accredited providers; and |
| |||||||
| |||||||
1 | (3) maintains a written collaborative agreement with a | ||||||
2 | collaborating physician pursuant to Section 4.3 of this | ||||||
3 | Act.
| ||||||
4 | (Source: P.A. 101-84, eff. 7-19-19.)
| ||||||
5 | (225 ILCS 15/4.3) | ||||||
6 | (Section scheduled to be repealed on January 1, 2027) | ||||||
7 | Sec. 4.3. Written collaborative agreements. | ||||||
8 | (a) A written collaborative agreement is required for all | ||||||
9 | prescribing psychologists practicing under a prescribing | ||||||
10 | psychologist license issued pursuant to Section 4.2 of this | ||||||
11 | Act. | ||||||
12 | (b) A written delegation of prescriptive authority by a | ||||||
13 | collaborating physician may only include medications for the | ||||||
14 | treatment of mental health disease or illness the | ||||||
15 | collaborating physician generally provides to his or her | ||||||
16 | patients in the normal course of his or her clinical practice | ||||||
17 | with the exception of the following: | ||||||
18 | (1) (blank); patients who are less than 17 years of | ||||||
19 | age or over 65 years of age; | ||||||
20 | (2) patients during pregnancy; | ||||||
21 | (3) patients with serious medical conditions, such as | ||||||
22 | heart disease, cancer, stroke, or seizures, and with | ||||||
23 | developmental disabilities and intellectual disabilities; | ||||||
24 | and | ||||||
25 | (4) prescriptive authority for benzodiazepine Schedule |
| |||||||
| |||||||
1 | III controlled substances. | ||||||
2 | (c) The collaborating physician shall file with the | ||||||
3 | Department notice of delegation of prescriptive authority and | ||||||
4 | termination of the delegation, in accordance with rules of the | ||||||
5 | Department. Upon receipt of this notice delegating authority | ||||||
6 | to prescribe any nonnarcotic Schedule III through V controlled | ||||||
7 | substances, the licensed clinical psychologist shall be | ||||||
8 | eligible to register for a mid-level practitioner controlled | ||||||
9 | substance license under Section 303.05 of the Illinois | ||||||
10 | Controlled Substances Act. | ||||||
11 | (d) All of the following shall apply to delegation of | ||||||
12 | prescriptive authority: | ||||||
13 | (1) Any delegation of Schedule III through V | ||||||
14 | controlled substances shall identify the specific | ||||||
15 | controlled substance by brand name or generic name. No | ||||||
16 | controlled substance to be delivered by injection may be | ||||||
17 | delegated. No Schedule II controlled substance shall be | ||||||
18 | delegated. | ||||||
19 | (2) A prescribing psychologist shall not prescribe | ||||||
20 | narcotic drugs, as defined in Section 102 of the Illinois | ||||||
21 | Controlled Substances Act. | ||||||
22 | Any prescribing psychologist who writes a prescription for | ||||||
23 | a controlled substance without having valid and appropriate | ||||||
24 | authority may be fined by the Department not more than $50 per | ||||||
25 | prescription and the Department may take any other | ||||||
26 | disciplinary action provided for in this Act. |
| |||||||
| |||||||
1 | All prescriptions written by a prescribing psychologist | ||||||
2 | must contain the name of the prescribing psychologist and his | ||||||
3 | or her signature. The prescribing psychologist shall sign his | ||||||
4 | or her own name. | ||||||
5 | (e) The written collaborative agreement shall describe the | ||||||
6 | working relationship of the prescribing psychologist with the | ||||||
7 | collaborating physician and shall delegate prescriptive | ||||||
8 | authority as provided in this Act. Collaboration does not | ||||||
9 | require an employment relationship between the collaborating | ||||||
10 | physician and prescribing psychologist. Absent an employment | ||||||
11 | relationship, an agreement may not restrict third-party | ||||||
12 | payment sources accepted by the prescribing psychologist. For | ||||||
13 | the purposes of this Section, "collaboration" means the | ||||||
14 | relationship between a prescribing psychologist and a | ||||||
15 | collaborating physician with respect to the delivery of | ||||||
16 | prescribing services in accordance with (1) the prescribing | ||||||
17 | psychologist's training, education, and experience and (2) | ||||||
18 | collaboration and consultation as documented in a jointly | ||||||
19 | developed written collaborative agreement. | ||||||
20 | (f) The agreement shall promote the exercise of | ||||||
21 | professional judgment by the prescribing psychologist | ||||||
22 | corresponding to his or her education and experience. | ||||||
23 | (g) The collaborative agreement shall not be construed to | ||||||
24 | require the personal presence of a physician at the place | ||||||
25 | where services are rendered. Methods of communication shall be | ||||||
26 | available for consultation with the collaborating physician in |
| |||||||
| |||||||
1 | person or by telecommunications in accordance with established | ||||||
2 | written guidelines as set forth in the written agreement. | ||||||
3 | (h) Collaboration and consultation pursuant to all | ||||||
4 | collaboration agreements shall be adequate if a collaborating | ||||||
5 | physician does each of the following: | ||||||
6 | (1) participates in the joint formulation and joint | ||||||
7 | approval of orders or guidelines with the prescribing | ||||||
8 | psychologist and he or she periodically reviews the | ||||||
9 | prescribing psychologist's orders and the services | ||||||
10 | provided patients under the orders in accordance with | ||||||
11 | accepted standards of medical practice and prescribing | ||||||
12 | psychologist practice; | ||||||
13 | (2) provides collaboration and consultation with the | ||||||
14 | prescribing psychologist in person at least once a month | ||||||
15 | for review of safety and quality clinical care or | ||||||
16 | treatment; | ||||||
17 | (3) is available through telecommunications for | ||||||
18 | consultation on medical problems, complications, | ||||||
19 | emergencies, or patient referral; and | ||||||
20 | (4) reviews medication orders of the prescribing | ||||||
21 | psychologist no less than monthly, including review of | ||||||
22 | laboratory tests and other tests as available. | ||||||
23 | (i) The written collaborative agreement shall contain | ||||||
24 | provisions detailing notice for termination or change of | ||||||
25 | status involving a written collaborative agreement, except | ||||||
26 | when the notice is given for just cause. |
| |||||||
| |||||||
1 | (j) A copy of the signed written collaborative agreement | ||||||
2 | shall be available to the Department upon request to either | ||||||
3 | the prescribing psychologist or the collaborating physician. | ||||||
4 | (k) Nothing in this Section shall be construed to limit | ||||||
5 | the authority of a prescribing psychologist to perform all | ||||||
6 | duties authorized under this Act. | ||||||
7 | (l) A prescribing psychologist shall inform each | ||||||
8 | collaborating physician of all collaborative agreements he or | ||||||
9 | she has signed and provide a copy of these to any collaborating | ||||||
10 | physician. | ||||||
11 | (m) No collaborating physician shall enter into more than | ||||||
12 | 3 collaborative agreements with prescribing psychologists.
| ||||||
13 | (Source: P.A. 101-84, eff. 7-19-19.)
| ||||||
14 | Section 99. Effective date. This Act takes effect upon | ||||||
15 | becoming law.
|